News INVO Bioscience, Inc.

Equities

INVO

US44984F4019

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-20 pm EDT			5-day change	1st Jan Change
0.929 ^USD	-5.69%		-23.85%	-31.19%

Apr. 18	Top Premarket Decliners	MT
Apr. 17	Sector Update: Health Care Stocks Retreating Late Afternoon	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

INVO Reports Record First Quarter 2024 Financial Results	May. 15	AQ
Exploring Emerging Companies with Key Developments Garnering Attention: INBS, INVO, VTAK, RCAT, GCTK	Apr. 22	AQ
Top Premarket Decliners	Apr. 18	MT
Sector Update: Health Care Stocks Retreating Late Afternoon	Apr. 17	MT
Top Midday Gainers	Apr. 17	MT
Traders Digest Earnings After Rate-Driven Losses, US Equity Futures Rebound Slightly	Apr. 17	MT
Top Premarket Gainers	Apr. 17	MT
INVO Reports Fourth Quarter and Full Year 2023 Financial Results	Apr. 16	AQ
INVO Bioscience : Reports Fourth Quarter and Full Year 2023 Financial Results - Form 8-K	Apr. 16	PU
INVO Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 16	CI
INVO Bioscience, Inc. announced that it has received $0.5 million in funding from FirstFire Capital Management LLC	Apr. 07	CI
INVO Bioscience, Inc. announced that it expects to receive $0.5 million in funding from FirstFire Capital Management LLC	Apr. 04	CI
INVO Bioscience : Private Placement - Form 8-K	Apr. 01	PU
Certain Options of INVO Bioscience, Inc. are subject to a Lock-Up Agreement Ending on 9-FEB-2024.	Feb. 08	CI
Certain Warrants of INVO Bioscience, Inc. are subject to a Lock-Up Agreement Ending on 9-FEB-2024.	Feb. 08	CI
Certain Common Stock of INVO Bioscience, Inc. are subject to a Lock-Up Agreement Ending on 9-FEB-2024.	Feb. 08	CI
INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors	Jan. 17	AQ
INVO Bioscience, Inc. announced that it expects to receive $5 million in funding from NAYA Biosciences Inc.	Dec. 28	CI
INVO Bioscience : Submission of Matters to a Vote of Security Holders - Form 8-K	Dec. 28	PU
NAYA Biosciences Announces Publication Of New Data For Its CD38-Targeted Flex-NK Bispecific Antibody in The American Society of Hematology s Blood Journal	Dec. 12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News INVO Bioscience, Inc.

Equities

INVO

US44984F4019

Summary

Filters